Publications by authors named "Maria Brattsand"

Claim this Profile
I
Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328.
Helena Järemo, Julius Semenas, Sofia Halin Bergström, Marie Lundholm, Elin Thysell, Maria Brattsand

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLK4T2 Is a Hormonally Regulated Transcript from the Locus.
Åke Lundwall, Erik Bovinder Ylitalo, Pernilla Wikström, Maria Brattsand

Int J Mol Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer.
Erik Bovinder Ylitalo, Elin Thysell, Mattias Landfors, Maria Brattsand, Emma Jernberg

Clin Epigenetics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Erik Bovinder Ylitalo, Elin Thysell, Camilla Thellenberg-Karlsson, Marie Lundholm, Anders Widmark, Maria Brattsand

Prostate· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Versatile and Robust Serine Protease Inhibitor Scaffold from .
Xingchen Chen, Darren Leahy, Jessica Van Haeften, Perry Hartfield, Peter J Prentis, Maria Brattsand

Mar Drugs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent, multi-target serine protease inhibition achieved by a simplified β-sheet motif.
Xingchen Chen, Blake T Riley, Simon J de Veer, David E Hoke, Jessica Van Haeften, Maria Brattsand

PLoS One· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype.
Meriem Haddada, Hend Draoui, Lydia Deschamps, Francine Walker, Tiphaine Delaunay, Maria Brattsand

Biol Chem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
Tiphaine Delaunay, Lydia Deschamps, Meriem Haddada, Francine Walker, Antoninus Soosaipillai, Maria Brattsand

Mol Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases.
Erik Djusberg, Emma Jernberg, Elin Thysell, Irina Golovleva, Pia Lundberg, Maria Brattsand

Prostate· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.
Simon J de Veer, Laetitia Furio, Joakim E Swedberg, Christopher A Munro, Maria Brattsand

J Invest Dermatol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype.
Petr Kasparek, Zuzana Ileninova, Olga Zbodakova, Ivan Kanchev, Oldrich Benada, Maria Brattsand

PLoS Genet· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors.
Simon J de Veer, Joakim E Swedberg, Maria Brattsand, Judith A Clements, Jonathan M Harris

Biol Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered protease inhibitors based on sunflower trypsin inhibitor-1 (SFTI-1) provide insights into the role of sequence and conformation in Laskowski mechanism inhibition.
Simon J de Veer, Joakim E Swedberg, Muharrem Akcan, K Johan Rosengren, Maria Brattsand

Biochem J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Over-expression of kallikrein related peptidases in palmoplantar pustulosis.
Takanori Kaneko, Masamoto Murakami, Mari Kishibe, Maria Brattsand, Vera B Morhenn

J Dermatol Sci· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis.
Kristoffer Brännström, Anders Ohman, Ulrich von Pawel Rammingen, Anders Olofsson, Maria Brattsand

Biol Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor.
Maria Brattsand, Kristina Stefansson, Thomas Hubiche, Stefan K Nilsson, Torbjörn Egelrud

J Invest Dermatol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Schistosoma mansoni protein Sm16/SmSLP/SmSPO-1 assembles into a nine-subunit oligomer with potential To inhibit Toll-like receptor signaling.
Kristoffer Brännström, Mikael E Sellin, Per Holmfeldt, Maria Brattsand, Martin Gullberg

Infect Immun· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases.
Kristina Stefansson, Maria Brattsand, Dirk Roosterman, Cordula Kempkes, Georgeta Bocheva

J Invest Dermatol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
Celine Deraison, Chrystelle Bonnart, Frederic Lopez, Celine Besson, Ross Robinson, Maria Brattsand

Mol Biol Cell· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.
Jean-Pierre Hachem, Fredrik Wagberg, Matthias Schmuth, Debra Crumrine, Willy Lissens, Maria Brattsand

J Invest Dermatol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum.
Kristina Stefansson, Maria Brattsand, Annelii Ny, Bo Glas, Torbjörn Egelrud

Biol Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteolytic cascade of kallikreins in the stratum corneum.
Maria Brattsand, Kristina Stefansson, Christine Lundh, Ylva Haasum, Torbjörn Egelrud

J Invest Dermatol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7.
Cécile Caubet, Nathalie Jonca, Maria Brattsand, Marina Guerrin, Dominique Bernard

J Invest Dermatol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
Ying Dong, Aneel Kaushal, Maria Brattsand, Jim Nicklin, Judith A Clements

Clin Cancer Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis